Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03872674 Completed - Clinical trials for Patients Undergoing Endoscopic Retrograde Cholangiopancreatography in Prone Position

A Trial Comparing High-flow Nasal Oxygen With Standard Management for Conscious Sedation During Endoscopic Retrograde Cholangiopancreatography in Prone Position

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Traditional conscious sedation for endoscopic retrograde cholangiopancreatography in prone position places patients at risk of desaturation, and high-flow nasal oxygen may reduce the risk. The aim of this study is to evaluate the role of high-flow nasal oxygen during endoscopic retrograde cholangiopancreatography. The investigators will compare the lowest SpO2 of standard nasal oxygen cannula group and that of high-flow humidified oxygen-delivery system group during the procedure.

NCT ID: NCT03872583 Completed - Multiple Sclerosis Clinical Trials

Understanding Magnetic Resonance Imaging in Multiple Sclerosis

UMIMS
Start date: March 15, 2019
Phase: N/A
Study type: Interventional

Magnetic resonance imaging (MRI) results play a major role in the lives of people with multiple sclerosis (pwMS). Even though MRI is used for diagnosis, prognosis and therapy control, pwMS' knowledge concerning this complex matter is scarce. Without adequate disease-specific knowledge, pwMS cannot truly make an informed choice when considering their MRI results (e.g. necessity of future MRI scans or therapy change). The investigators have developed an innovative, evidence-based and interactive online education tool called "Understanding MRI in MS", which incorporates all relevant information about MRI in MS and its implications in disease management. In this randomized, controlled and double-blind trial the tool's effect on MRI-specific knowledge, self-perceived competence and involvement in medical decision, that are based on MRI results will be assessed.

NCT ID: NCT03872388 Completed - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Start date: January 14, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well atorvastatin works in treating patients with stages IIb-III triple negative breast cancer who did not achieve a pathologic complete response to neoadjuvant chemotherapy. Pathologic complete response is the lack of all signs of cancer in tissue samples removed during surgery after upfront chemotherapy. Atorvastatin is used for the treatment of high cholesterol and may reduce the risk of triple negative breast cancer from coming back. Triple-negative breast cancer is a type of breast malignancy that is comprised of cancer cells that do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein. Patients with TNBC do not have established systemic therapies such as anti-estrogens or HER2-targeting agents to reduce recurrence after surgery, and residual cancer found at surgery is associated with higher relapse rate.

NCT ID: NCT03872206 Completed - Clinical trials for Advanced Cancers Associated With Mesothelin Expression

Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression

Start date: April 16, 2019
Phase: Phase 1
Study type: Interventional

An open-label, Phase 1/2a study of HPN536 as monotherapy to assess the safety, tolerability and PK in patients with advanced cancers associated with mesothelin expression.(Phase 2 portion of the study was not conducted.)

NCT ID: NCT03872154 Completed - Clinical trials for Code Status Discussions With Medical In-patients

Checklist-guided Shared Decision-making for Code Status Discussions in Medical Inpatients.

Start date: June 13, 2019
Phase: N/A
Study type: Interventional

This cluster-randomized, multicenter trial is designed to investigate the effect of checklist-guided shared decision-making including decision aids and communication of expected outcome on patients' decision regarding their code status, and at the same time, if it improves decision-making quality as judged by patient's decisional comfort, patient knowledge and involvement in decision-making and patient satisfaction. Patients in whom resuscitation is considered as futile will be treated separately in an ancillary project. In these patients a checklist to communicate the futility and the medical consequences will be used.

NCT ID: NCT03871972 Completed - Clinical trials for Hutchinson-Gilford Progeria Syndrome

Umbilical Cord Blood Transfusion in Progeria Syndrome

Start date: March 5, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a pilot study on safety and efficacy of umbilical cord blood therapy for patients with Hutchinson Gilford Progeria syndrome (HGPS). This is an 1 year trial with 3 IV infusions (4 months apart from each infusion) of umbilical cord blood units with oral Sirolimus to see the safety and efficacy.

NCT ID: NCT03871803 Completed - Clinical trials for Heart Failure With Normal Ejection Fraction

β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)

Preserve-HR
Start date: October 1, 2018
Phase: Phase 4
Study type: Interventional

The pathophysiology of heart failure with preserved ejection fraction (HFpEF) is complex and multifactorial. Chronotropic incompetence has emerged as a crucial mechanism, particularly in elderly patients. Betablockers, drugs with negative chronotropic effect, are commonly used in HFpEF, despite current evidence does not support its routine use in these patients. The aim of this work is to evaluate the effect of betablockers withdrawal in patients with HFpEF and chronotropic incompetence on functional capacity assessed by the peak oxygen consumption at maximal exercise (peakVO2) at 15 and 30 days after the intervention

NCT ID: NCT03871764 Completed - Clinical trials for Leiden Factor V Deficiency,Preeclampsia

Prediction of Outcome in Severe Preeclampsia

Start date: December 1, 2015
Phase:
Study type: Observational [Patient Registry]

this summary studied the predictive values of factor V Leiden mutation , doppler indices , placental pathology to unfavorable fetal and maternal outcomes

NCT ID: NCT03871283 Completed - Clinical trials for Anticoagulants and Bleeding Disorders

Anticoagulation and Antiplatelet Management During Perioperative Period

OMAHA
Start date: January 1, 2019
Phase:
Study type: Observational

the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.

NCT ID: NCT03870737 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Four-week Open-trial Extension TNS for ADHD

Start date: December 1, 2014
Phase: N/A
Study type: Interventional

The purpose of this study will be to offer children previously randomized to sham treatment in a 5-week double-blind sham controlled study of Trigeminal Nerve Stimulation for ADHD (NCT02155608) an opportunity to receive 4-weeks active TNS treatment.